期刊文献+

犬血浆中替格瑞洛及其活性代谢产物的LC-MS/MS法测定 被引量:4

Determination of Ticagrelor and Its Active Metabolite in Dog Plasma by LC-MS/MS
原文传递
导出
摘要 建立了液相色谱-串联质谱法同时测定犬血浆中的替格瑞洛(1)及其主要活性代谢产物AR-C124910XX (2).使用C18色谱柱,以乙腈∶2 mmol/L乙酸铵溶液(70∶30)为流动相,地西泮为内标,采用TQ-MS检测器,电喷雾离子源(ESI),以正离子多反应监测(MRM)方式进行定量分析,监测离子对m/z 523.3→m/z 127.1 (1)、m/z 479.3→m/z 153.1 (2)和m/z 284.9→m/z 193.0(内标).1、2均在50~10 000 ng/ml范围内线性关系良好;提取回收率为109.8%~ 115.1%和109.3%~114.5%,日内RSD≤6.8%,日间RSD≤14.2%. A LC-MS/MS method was established for the determination ofticagrelor (1) and its active metabolite AR-C124910XX (2) in dog plasma with diazepam as the internal standard.A C18 column was used,with the mobile phase of acetonitrile ∶ 2 mmol/L ammonium acetate solution (70 ∶ 30).An electrospray ionization source (ESI) was operated in positive ion mode and multiple reaction monitoring (MRM) mode with the transitions of m/z 523.3→m/z 127.1 (1),m/z 479.3→m/z 153.1 (2) and m/z 284.9→m/z 193.0 (diazepam),respectively.It was linear for 1 and 2 in the range of 50-10 000 ng/ml.Their extraction recoveries were 109.8%-115.1% and 109.3%-114.5%,with the intra-day RSDs no more than 6.8 % and inter-day RSDs no more than 14.2 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第11期1050-1053,共4页 Chinese Journal of Pharmaceuticals
关键词 替格瑞洛 AR-C124910XX 液相色谱-串联质谱 测定 ticagrelor AR-C124910XX LC-MS/MS determination
  • 相关文献

参考文献3

  • 1Sill6n H, Cook M, Davis P. Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC-MS/MS [J]. J Chromatogr B, 20 ! 1,879 (23) : 2315-2322.
  • 2Astra Zeneca. Label information: full prescribing information[EB/OL]. [2013-12-13]. http://www.accessdata.fda.gov/ drugsat fda_docs/label/2013/022433 sO 101bl.pdf.
  • 3Astra Zeneca. Pharmacology/toxicology review and evaluation [EB/OL]. [2011-03-31 ]. http://www.accessdata. fda. gov/drugsatfda_docs/nda/2011/022433Origls000PharmR. pdf.

同被引文献91

  • 1陈蓉,谢梅林.新型抗血栓药物作用机制研究进展[J].中国药理学通报,2004,20(8):857-860. 被引量:6
  • 2杨季菱,徐宏平,丁既鹏.人血浆中头孢克洛高效液相色谱法与微生物法测定[J].郑州大学学报(医学版),2005,40(5):911-913. 被引量:3
  • 3陈宁,张琪,杜宇,陈国广,朱玲玲.黄芪甲苷在大鼠体内的药代动力学和组织分布研究[J].生物加工过程,2006,4(3):67-72. 被引量:13
  • 4钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 5姚懿,袁晋青.新型抗血小板药物普拉格雷、替格瑞洛与氯吡格雷的临床对比研究进展[J].中华临床医师杂志(电子版),2013,7(19):8870-8873.
  • 6JNEID H, ANDERSON JL, WRIGHT RS,et al. 2012 ACCF/ AHA focused update of the guideline for the management of pa- tients with unstable angina/non-ST-elevation myocardial infarc- tion ( updating the 2007 guideline and replacing the 2011 focused update) : a report of tle American College of Cardiology Founda- tion/American Heart Association Task Force on Practice Guide- lines [ J ]. J Am College Cardiol, 2012, 60 ( 7 ) : 645 - 681.
  • 7O'GARA PT, KUSHNER FG, ASCHEIM DD,et al. 2013 AC- CF/'AHA guideline for the management of ST-elevation myocardi- al infarction: executive summary: a report of the American Col- lege of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardi- ovascular Angiography and Interventions [J]. Catheter Cardiovasc lnterv, 2013, 82(1): E1 -27.
  • 8LEVINE GN, BATES ER, BLANKENSHIP JC,et al. 2011 AC- CF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/Ameri- can Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ J ]. J Am College Cardiol, 2011, 58(24) : e44 -e122.
  • 9MATETZKY S, SHENKROAN B, GUETTA V. Clopidogrel re- sistance is associated with increased risk of recurrent athemthm- mbotie events in patients with acute myocardial infarction [ J ]. Circulation, 2004,109 ( 25 ) : 3171 - 3175.
  • 10VAN GIEZEN JJJ, NILSSON L, BERNTSSON P, et al. Ti- cagrelor binds to human P2Y12 independently from ADP but an- tagonizes ADP-induced receptor signaling and platelet aggregation [ J ]. J Thrombos Haemostas, 2009, 7 (9) : 1556 - 1565.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部